Similar articles

• In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.

  Focht J, Klietmann W, Nösner K. Focht J, et al. Arzneimittelforschung. 1988 Aug;38(8):1085-8. Arzneimittelforschung. 1988. PMID: 3264166
• [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].

  Riou B, Richard C, Rimailho A, Bottineau G, Coquin Y, Auzepy P. Riou B, et al. Presse Med. 1984 Jun 23;13(26):1637-8. Presse Med. 1984. PMID: 6234571 French. No abstract available.
• Trimethoprim resistance and single-agent use.

  Maskell R, Pead L. Maskell R, et al. Lancet. 1989 Sep 2;2(8662):557-8. doi: 10.1016/s0140-6736(89)90673-9. Lancet. 1989. PMID: 2570249 No abstract available.
• Trimethoprim-sulfamethoxazole for bacterial meningitis.

  Levitz RE, Quintiliani R. Levitz RE, et al. Ann Intern Med. 1984 Jun;100(6):881-90. doi: 10.7326/0003-4819-100-6-881. Ann Intern Med. 1984. PMID: 6372565 Review.
• Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

  Wormser GP, Keusch GT, Heel RC. Wormser GP, et al. Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002. Drugs. 1982. PMID: 6759092 Review. No abstract available.